Clinical Trial Update: Cetuximab Plus Conformal Thoracic Radiotherapy in Patients (Pts) With Inoperable or Unresectable Locally Advanced Non-Small Cell Lung Cancer (LA - NSCLC) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cetuximab with conformal thoracic radiotherapy in patients with inoperable or unresectable locally advanced non-small cell lung cancer;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-03-04